Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1560]
News [2057]
Articles [123]
Editorials [10]
Conferences [114]
elearning [20]
Latest advances in pancreatic cancer treatment and impact on practice
Prof Eric Van Cutsem and Dr Talia Golan
Latest advances in pancreatic cancer treatment and impact on practice ( Prof Eric Van Cutsem and Dr Talia Golan )
10 Jul 2019
Lifestyle-based prevention strategies to decrease cancer risk
Dr Jennifer Ligibel - Dana Farber Cancer Institute, Boston, USA
Lifestyle-based prevention strategies to decrease cancer risk ( Dr Jennifer Ligibel - Dana Farber Cancer Institute, Boston, USA )
10 Jul 2019
Implementing national cancer control plans
Dr Eduardo Cazap and Dr Lisa Stevens
Implementing national cancer control plans ( Dr Eduardo Cazap and Dr Lisa Stevens )
24 Jun 2019
Tackling the increase in cancer cases worldwide
Dr Eduardo Cazap and Prof Tezer Kutluk
Tackling the increase in cancer cases worldwide ( Dr Eduardo Cazap and Prof Tezer Kutluk )
21 Jun 2019
How will ASCO combat cancer disparities?
Dr Eduardo Cazap, Dr Richard Schilsky
How will ASCO combat cancer disparities? ( Dr Eduardo Cazap, Dr Richard Schilsky )
21 Jun 2019
Controlling CRS-related coagulopathy improves the safety of CAR T-cell therapy...
Dr Heng Mei - Huazhong University of Science and Technology, Wuhan, China
Controlling CRS-related coagulopathy improves the safety of CAR T-cell therapy for MM ( Dr Heng Mei - Huazhong University of Science and Technology, Wuhan, China )
20 Jun 2019
ICARIA results: Treating RRMM patients with isatuximab, pomalidomide and low...
Prof Paul Richardson - Dana-Farber Cancer Institute, Boston, USA
ICARIA results: Treating RRMM patients with isatuximab, pomalidomide and low-dose dexamethasone ( Prof Paul Richardson - Dana-Farber Cancer Institute, Boston, USA )
20 Jun 2019
HORIZON update: Using melflufen to treat RRMM patients refractory to...
Prof Paul Richardson - Dana-Farber Cancer Institute, Boston, USA
HORIZON update: Using melflufen to treat RRMM patients refractory to daratumumab and/or pomalidomide ( Prof Paul Richardson - Dana-Farber Cancer Institute, Boston, USA )
20 Jun 2019
Chemoimmunotherapy or BTK inhibition for patients with CLL
Dr Othman Al-Sawaf - University of Cologne, Cologne, Germany
Chemoimmunotherapy or BTK inhibition for patients with CLL ( Dr Othman Al-Sawaf - University of Cologne, Cologne, Germany )
20 Jun 2019
MOR208 plus lenalidomide in r-r diffuse large B-cell lymphoma
Dr Johannes Düll - University of Würzburg, Würzburg, Germany
MOR208 plus lenalidomide in r-r diffuse large B-cell lymphoma ( Dr Johannes Düll - University of Würzburg, Würzburg, Germany )
20 Jun 2019
Using bioinformatics and genomics to treat AML
Prof Torsten Haferlach - MLL Münchner Leukämielabor GmbH, Munich, Germany
Using bioinformatics and genomics to treat AML ( Prof Torsten Haferlach - MLL Münchner Leukämielabor GmbH, Munich, Germany )
20 Jun 2019
The changing landscape of AML
Prof Torsten Haferlach - MLL Münchner Leukämielabor GmbH, Munich, Germany
The changing landscape of AML ( Prof Torsten Haferlach - MLL Münchner Leukämielabor GmbH, Munich, Germany )
20 Jun 2019

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation